|
rs899127658
|
|
Deep Vein Thrombosis
|
|
0.090 |
GeneticVariation
|
BEFREE |
Coagulation factor V gene 1691G>A polymorphism as an indicator for risk and prognosis of lower extremity deep venous thrombosis in Chinese Han population.
|
29851809 |
2018 |
|
rs899127658
|
|
Deep Vein Thrombosis
|
|
0.090 |
GeneticVariation
|
BEFREE |
To determine if the deep vein thrombosis was of genetic origin, a peripheral blood DNA sample was analysed for the presence of the three most frequent mutations associated with thrombotic events: factor V Leiden (1691G>A), prothrombin (20210G>A) and methylene tetrahydrofolate reductase (677C>T).
|
24627725 |
2014 |
|
rs899127658
|
|
Deep Vein Thrombosis
|
|
0.090 |
GeneticVariation
|
BEFREE |
The aim of present study was to investigate the prevalence of factor V Leiden (FVL) c.1691G>A, prothrombin g.20210G>A and methylenetetrahydrofolate reductase (MTHFR) c.677C>T in deep vein thrombosis (DVT) patients and their possible association with DVT in western Iran.
|
20479641 |
2010 |
|
rs899127658
|
|
Deep Vein Thrombosis
|
|
0.090 |
GeneticVariation
|
BEFREE |
Insofar as the inherited prothrombotic single nucleotide polymorphisms (SNPs) factor V G1691A (FV-Leiden), prothrombin (PRT) G20210A, and methylenetetrahydrofolate reductase (MTHFR), C677T are inherited risk factors of venous thromboembolism (VTE), the aim of this study was to determine the prevalence of single and combined SNPs in 198 patients with documented deep venous thrombosis (DVT), and 697 control subjects, and to estimate the associated risks.
|
16082606 |
2005 |
|
rs899127658
|
|
Deep Vein Thrombosis
|
|
0.090 |
GeneticVariation
|
BEFREE |
Time from start of chemotherapy infusion to DVT was not significantly different between patients with (median 31 days) and without (median 43 days) G1691A factor V mutation (P = 0.6).
|
15033664 |
2004 |
|
rs899127658
|
|
Deep Vein Thrombosis
|
|
0.090 |
GeneticVariation
|
BEFREE |
Possible roles of methylenetetrahydrofolate reductase (MTHFR) gene C677T, factor V (FV) gene G1691A (Leiden), and prothrombin gene G20210A polymorphisms in venous thrombogenesis were evaluated in patients with BD; 100 healthy people, 30 BD patients without DVT, 30 BD patients with DVT, and 30 patients with idiopathic DVT were studied with the restriction fragment length polymorphism method for these 3 polymorphisms.
|
11128675 |
2000 |
|
rs899127658
|
|
Deep Vein Thrombosis
|
|
0.090 |
GeneticVariation
|
BEFREE |
We investigated the prevalence of a genetic variation in the factor V gene (G1691A Leiden mutation) and the prothrombin gene (G20210A) using polymerase chain reaction techniques in samples from 500 normal Thai population and among 50 unselected Thai patients with an objectively confirmed history of deep venous thrombosis.
|
10996828 |
2000 |
|
rs899127658
|
|
Deep Vein Thrombosis
|
|
0.090 |
GeneticVariation
|
BEFREE |
In contrast, the frequency of the factor V G1691A mutation was similar in subjects with portal vein thrombosis and in controls but was increased in patients with deep vein thrombosis (P = 0.0001).
|
9869612 |
1999 |
|
rs899127658
|
|
Deep Vein Thrombosis
|
|
0.090 |
GeneticVariation
|
BEFREE |
The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels.
|
10065893 |
1999 |